Arrhythmogenic Right Ventricular Dysplasia
Recent clinical, regulatory, research and industry developments relating to this disease.
2023 ESC Guidelines for the management of cardiomyopathies.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 2 clinical trials expected to report results, the earliest in Q1 2027.
Clinical MilestonesViewHide
- 2026-06-01Local Inflammation in Arrhythmogenic Right Ventricular CardiomyopathyResults expected Q1 2027
- 2026-02-09Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD: a Double-blind Multicentre Prospective Randomized Study.Results expected Q4 2027
- 2026-04-15Phase 1b Study of IC14 in Arrhythmogenic CardiomyopathyCompleted
- 2026-06-01ClinicalLocal Inflammation in Arrhythmogenic Right Ventricular CardiomyopathyResults expected Q1 2027
- 2026-04-15ClinicalPhase 1b Study of IC14 in Arrhythmogenic CardiomyopathyCompleted
- 2026-02-09ClinicalBlockade of the Renin-angiotensin-aldosterone System in Patients With ARVD: a Double-blind Multicentre Prospective Randomized Study.Results expected Q4 2027
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Arrhythmogenic Right Ventricular Dysplasia2
- Cardiomyopathies1
- Defibrillators, Implantable1
- Echocardiography1
- Electrocardiography1
- Electrocardiography, Ambulatory1
- Genetic Therapy1
- Magnetic Resonance Imaging1
Leading journals3
- Circulation2
- European heart journal1
- Nature cardiovascular research1
Leading researchers8
- Basso C2
- Corrado D2
- Antzelevitch C1
- Arbelo E1
- Arbustini E1
- Barriales-Villa R1
- Bauce B1
- Bezzina CR1
Affiliations (unnormalised)3
- Masonic Medical Research Laboratory1
- University of Arizona1
- University of California San Diego1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.